Rodger Novak - 30 Jun 2021 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
President, Director
Signature
/s/ Michael Esposito, attorney-in-fact
Issuer symbol
CRSP
Transactions as of
30 Jun 2021
Net transactions value
-$4,125,000
Form type
4
Filing time
01 Jul 2021, 17:43:55 UTC
Previous filing
30 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRSP Common Shares Sale $4,125,000 -25,000 -4.2% $165.00 573,007 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.